In this sample of 364 brain donors with autopsy confirmed CTE, we examined the contribution of global and regional p-tau density to informant-reported cognitive, functional, and neuropsychiatric symptoms (including symptoms of neurobehavioral dysregulation, depression and apathy). This evidence concerns the gene MAPT and depressive symptom measurement.